Newly available Medicaid claims data reveal a wide range in the occurrence of opioid use disorder (OUD) and the medication being administered to enrollees suffering from the condition across U.S. states and counties.
“The clinical takeaway [from these data] is that there are lost opportunities in providing the best possible OUD treatment, because some geographic areas have substantially more elevated OUD medication rates than other areas,” researcher Stephan Lindner, PhD, a health